Results 241 to 250 of about 93,853 (343)
Response to the Letter to the Editor "Advancing Clinical and Ethical Dimensions of Deep Learning in Cardiovascular Imaging". [PDF]
Verma A, Uniyal P, Banerjee SP.
europepmc +1 more source
ABSTRACT Background Prosthesis‐patient mismatch (PPM) remains common following transcatheter aortic valve replacement (TAVR) and is associated with worse clinical outcomes. PPM is of particular concern in small aortic annuli (SAA). Aims To compare the incidence, predictors, and long‐term impact of PPM in SAA TAVR.
Itamar Loewenstein +9 more
wiley +1 more source
Comment on "Laparoscopic and Endoscopic Cooperative Surgery for Gastric Cancer as an Alternative Treatment in Elderly Patients: A Prospective Observational Study". [PDF]
Sah SS, Kumbhalwar A.
europepmc +1 more source
Recent Advances in Chemical Probing Strategies for RNA Structure Determination in Vivo
This Review illustrates how structural probes combined with advanced sequencing technologies are revolutionizing our ability to map RNA structures and interactions within living cells. It highlights the development of innovative strategies tailored to probe RNA structures in particular biological contexts.
Maryana Yarshova +2 more
wiley +1 more source
Long-Term Impact of EGUIDE Training on Facility-Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder-A Methodological Reflection. [PDF]
Rizvi GS.
europepmc +1 more source
Key improvements obtained by incorporating nanoparticles into a lab‐scale SAGD process configuration. The bar plots show enhanced oil recovery, reduced viscosity, and increased asphaltene adsorption in nanoparticle‐assisted scenarios compared with conventional SAGD.
Luis Prada +6 more
wiley +1 more source
Commentary: ED<sub>50</sub> and ED<sub>95</sub> of hypobaric ropivacaine during unilateral spinal anesthesia in older patients undergoing hip replacement surgery. [PDF]
Li S, Tian Y, Tian S, Tan T, Bu S.
europepmc +1 more source
Straight to Phase III: Model‐informed approach speeds depemokimab clinical development in interleukin‐5‐driven diseases. IL‐5, a key mediator of type 2 inflammation, underlies various diseases, including severe asthma, CRSwNP, EGPA, and HES. Reduction in blood eosinophil count (BEC), a biomarker of IL‐5 activity, is commonly used to evaluate the ...
Chiara Zecchin +6 more
wiley +1 more source

